CoChat

Iron Metabolism in Obesity and Metabolic Syndrome

Open access
González-Domínguez, Álvaro, Visiedo-García, Francisco M., Domínguez-Riscart, Jesús, González-Domínguez, Raúl, Mateos, Rosa M., Lechuga-Sancho, Alfonso María · 2020 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 161 of the 162 references it cites were found in a registry or an index.

Abstract

Obesity is an excessive adipose tissue accumulation that may have detrimental effects on health. Particularly, childhood obesity has become one of the main public health problems in the 21st century, since its prevalence has widely increased in recent years. Childhood obesity is intimately related to the development of several comorbidities such as nonalcoholic fatty liver disease, dyslipidemia, type 2 diabetes mellitus, non-congenital cardiovascular disease, chronic inflammation and anemia, among others. Within this tangled interplay between these comorbidities and associated pathological conditions, obesity has been closely linked to important perturbations in iron metabolism. Iron is the second most abundant metal on Earth, but its bioavailability is hampered by its ability to form highly insoluble oxides, with iron deficiency being the most common nutritional disorder. Although every living organism requires iron, it may also cause toxic oxygen damage by generating oxygen free radicals through the Fenton reaction. Thus, iron homeostasis and metabolism must be tightly regulated in humans at every level (i.e., absorption, storage, transport, recycling). Dysregulation of any step involved in iron metabolism may lead to iron deficiencies and, eventually, to the anemic state related to obesity. In this review article, we summarize the existent evidence on the role of the most recently described components of iron metabolism and their alterations in obesity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms21155529

Cites

161 of 161 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Volumetric dispersion of erythrocytes in pubescent controls versus obese children. ** p < 0.01.
Figure 1 Volumetric dispersion of erythrocytes in pubescent controls versus obese children. ** p < 0.01.CC BY · PubMed Central
Figure 2 Physiology of Iron Metabolism. Iron ingested from the diet (A), is reduced from Fe3+ to Fe2+ in the stomach (B). In the duodenum, enterocytes transport Fe2+, heme groups and ferritin across the microvillus membrane (C). Fe2+ is transported by ferroportin across the basolateral membrane into the portal system and must be oxidized to Fe3+ for binding to transferrin and other molecules with high affinity for Fe3+ to be transported to the liver. Transferrin-bound iron is necessary for cells expressing transferrin receptors for uptake of iron, mainly for production of heme proteins (D). Transferrin-bound iron is taken up by myocytes, where Fe3+ is oxidized again to Fe2+ in order to be incorporated into myoglobin (E), hepatocytes being the main ferritin store (F), and by proerythroblasts for synthesis of hemoglobin (G). When mature erythrocytes die, macrophages liberate Fe2+ from hemoglobin, which is oxidized again to recirculate bound to transferrin (H). Finally, 1–2 mg iron is lost per day from the organism by desquamation, bleeding and other mechanisms (I). Vit. C: vitamin C; DMT1: divalent metal transporter 1; ZIP 14/8: Zrt–Irt-like protein 14 and 8; DcytB: duodenal cytochrome B; STEAP 2: six-transmembrane epithelial antigen of the prostate 2; HCP1: heme carrier protein 1; AP2: adaptor-related 2 protein; PCBP: poly (rC) binding protein; LIP: labile iron pool; HO1: heme oxygenase 1; FPN1: ferroportin 1; HEPH: hephaestin; CP: ceruloplasmin; FLVCR: feline leukemia virus subgroup C; BCRP: breast cancer-resistant protein; Tf: transferrin; TfR: transferrin receptor; CAT: catalase; Scara 5: scavenger receptor class A, member 5; TIM2: T-cell immunoglobulin and mucin domain-containing protein 2; STEAP 3: six-transmembrane epithelial antigen of the prostate 3; NCOA4: nuclear receptor coactivator 4; BFU-e: burst forming unit-erythroid; CFU-e: colony forming unit-erythroid; EPO: erythropoietin; Hb: hemoglobin; Hp: haptoglobin; CD163: cluster of differentiation 163; CD91/LRP: cluster of differentiation/ low-density lipoprotein receptor related protein; HRG: heme responsive gene.
Figure 2 Physiology of Iron Metabolism. Iron ingested from the diet (A), is reduced from Fe3+ to Fe2+ in the stomach (B). In the duodenum, enterocytes transport Fe2+, heme groups and ferritin across the microvillus membrane (C). Fe2+ is transported by ferroportin across the basolateral membrane into the portal system and must be oxidized to Fe3+ for binding to transferrin and other molecules with high affinity for Fe3+ to be transported to the liver. Transferrin-bound iron is necessary for cells expressing transferrin receptors for uptake of iron, mainly for production of heme proteins (D). Transferrin-bound iron is taken up by myocytes, where Fe3+ is oxidized again to Fe2+ in order to be incorporated into myoglobin (E), hepatocytes being the main ferritin store (F), and by proerythroblasts for synthesis of hemoglobin (G). When mature erythrocytes die, macrophages liberate Fe2+ from hemoglobin, which is oxidized again to recirculate bound to transferrin (H). Finally, 1–2 mg iron is lost per day from the organism by desquamation, bleeding and other mechanisms (I). Vit. C: vitamin C; DMT1: divalent metal transporter 1; ZIP 14/8: Zrt–Irt-like protein 14 and 8; DcytB: duodenal cytochrome B; STEAP 2: six-transmembrane epithelial antigen of the prostate 2; HCP1: heme carrier protein 1; AP2: adaptor-related 2 protein; PCBP: poly (rC) binding protein; LIP: labile iron pool; HO1: heme oxygenase 1; FPN1: ferroportin 1; HEPH: hephaestin; CP: ceruloplasmin; FLVCR: feline leukemia virus subgroup C; BCRP: breast cancer-resistant protein; Tf: transferrin; TfR: transferrin receptor; CAT: catalase; Scara 5: scavenger receptor class A, member 5; TIM2: T-cell immunoglobulin and mucin domain-containing protein 2; STEAP 3: six-transmembrane epithelial antigen of the prostate 3; NCOA4: nuclear receptor coactivator 4; BFU-e: burst forming unit-erythroid; CFU-e: colony forming unit-erythroid; EPO: erythropoietin; Hb: hemoglobin; Hp: haptoglobin; CD163: cluster of differentiation 163; CD91/LRP: cluster of differentiation/ low-density lipoprotein receptor related protein; HRG: heme responsive gene.CC BY · PubMed Central
Figure 3 Iron metabolism dysregulation in obesity. Obesity influences iron metabolism at many steps of the cycle. No alterations have been proven in iron ingested from the diet (A), nor in its reduction from Fe3+ to Fe2+ in the stomach (B). In the duodenum enterocytes in obese patients, DMT1 density increases at the apical membrane, whereas ZIP14 and 8 co transporters decrease. HO1 levels increase intracellularly and at the basal membrane CP and FLVCR increase, whereas FPN1, BCRP and HEPH decrease (C). Ferritin circulating levels increase (D). Myocyte and hepatocyte transferrin receptor density increases, together with an increase in DMT1 and a decrease in ZIP14 (E,F). Additionally, in hepatocytes, NCOA4 decreases, preventing ferritin degradation, and HEPH and FPN1 decrease, reducing the Fe2+ sent to circulation (F). Decreased levels of transferrin receptors are found in proerythroblasts (G). Changes in macrophages recycling Fe2+ from hemoglobin include an increase in hemopexin, Hp and CD163, indicating an increase in the capacity to uptake heme groups and hemoglobin, and an increase in CP with a decrease in FPN1, suggesting a decrease in the Fe2+ liberated to circulation, but an increased oxidizing capacity to Fe3+ (H). Finally, no changes in daily iron loss has been described (I). Vit. C: vitamin C; DMT1: divalent metal transporter 1; ZIP 14/8: Zrt–Irt-like protein 14 and 8; DcytB: duodenal cytochrome B; STEAP 2: six-transmembrane epithelial antigen of the prostate 2; HCP1: heme carrier protein 1; AP2: adaptor-related 2 protein; PCBP: poly (rC) binding protein; LIP: labile iron pool; HO1: heme oxygenase 1; FPN1: ferroportin 1; HEPH: hephaestin; CP: ceruloplasmin; FLVCR: feline leukemia virus subgroup C; BCRP: breast cancer-resistant protein; Tf: transferrin; TfR: transferrin receptor; CAT: catalase; Scara 5: scavenger receptor class A, member 5; TIM2: T-cell immunoglobulin and mucin domain-containing protein 2; STEAP 3: six-transmembrane epithelial antigen of the prostate 3; NCOA4: nuclear receptor coactivator 4; BFU-e: burst forming unit-erythroid; CFU-e: colony forming unit-erythroid; EPO: erythropoietin; Hb: hemoglobin; Hp: haptoglobin; CD163: cluster of differentiation 163; CD91/LRP: cluster of differentiation/ low-density lipoprotein receptor related protein; HRG: heme responsive gene. Upregulated transporters and enzymes are shown with a green arrow pointing upwards, whereas downregulated transporters and enzymes are shown with a red arrow pointing down.
Figure 3 Iron metabolism dysregulation in obesity. Obesity influences iron metabolism at many steps of the cycle. No alterations have been proven in iron ingested from the diet (A), nor in its reduction from Fe3+ to Fe2+ in the stomach (B). In the duodenum enterocytes in obese patients, DMT1 density increases at the apical membrane, whereas ZIP14 and 8 co transporters decrease. HO1 levels increase intracellularly and at the basal membrane CP and FLVCR increase, whereas FPN1, BCRP and HEPH decrease (C). Ferritin circulating levels increase (D). Myocyte and hepatocyte transferrin receptor density increases, together with an increase in DMT1 and a decrease in ZIP14 (E,F). Additionally, in hepatocytes, NCOA4 decreases, preventing ferritin degradation, and HEPH and FPN1 decrease, reducing the Fe2+ sent to circulation (F). Decreased levels of transferrin receptors are found in proerythroblasts (G). Changes in macrophages recycling Fe2+ from hemoglobin include an increase in hemopexin, Hp and CD163, indicating an increase in the capacity to uptake heme groups and hemoglobin, and an increase in CP with a decrease in FPN1, suggesting a decrease in the Fe2+ liberated to circulation, but an increased oxidizing capacity to Fe3+ (H). Finally, no changes in daily iron loss has been described (I). Vit. C: vitamin C; DMT1: divalent metal transporter 1; ZIP 14/8: Zrt–Irt-like protein 14 and 8; DcytB: duodenal cytochrome B; STEAP 2: six-transmembrane epithelial antigen of the prostate 2; HCP1: heme carrier protein 1; AP2: adaptor-related 2 protein; PCBP: poly (rC) binding protein; LIP: labile iron pool; HO1: heme oxygenase 1; FPN1: ferroportin 1; HEPH: hephaestin; CP: ceruloplasmin; FLVCR: feline leukemia virus subgroup C; BCRP: breast cancer-resistant protein; Tf: transferrin; TfR: transferrin receptor; CAT: catalase; Scara 5: scavenger receptor class A, member 5; TIM2: T-cell immunoglobulin and mucin domain-containing protein 2; STEAP 3: six-transmembrane epithelial antigen of the prostate 3; NCOA4: nuclear receptor coactivator 4; BFU-e: burst forming unit-erythroid; CFU-e: colony forming unit-erythroid; EPO: erythropoietin; Hb: hemoglobin; Hp: haptoglobin; CD163: cluster of differentiation 163; CD91/LRP: cluster of differentiation/ low-density lipoprotein receptor related protein; HRG: heme responsive gene. Upregulated transporters and enzymes are shown with a green arrow pointing upwards, whereas downregulated transporters and enzymes are shown with a red arrow pointing down.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. Bueno, 2014, Las alteraciones metabólicas asociadas a la obesidad están ya presentes en los primeros años de vida: Estudio colaborativo español, Nutr. Hosp., 30, 787
  2. Lowe, 1999, Activated Protein C Resistance and the FV:R506Q Mutation in a Random Population Sample, Thromb. Haemost., 81, 914

Cited by

See all 242

Metadata

Authors
González-Domínguez, Á., Visiedo-García, F. M., Domínguez-Riscart, J., González-Domínguez, R., Mateos, R. M., & Lechuga-Sancho, A. M.
Affiliations
  • Inflammation, Nutrition, Metabolism and Oxidative Stress Study Group (INMOX), Biomedical Research and Innovation Institute of Cádiz (INiBICA), Research Unit, Puerta del Mar University Hospital, 11009 Cádiz, Spain
  • Pediatric Endocrinology, Department of Pediatrics, Puerta del Mar University Hospital, 11009 Cádiz, Spain
  • Department of Chemistry, Faculty of Experimental Sciences, University of Huelva, 21007 Huelva, Spain
  • Universidad de Cádiz (ES)
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-08-01
Volume
21
Issue
15
Pages
5529
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3046585788
Cited by
227
References
162
Citations by year
2026: 24 · 2025: 48 · 2024: 44 · 2023: 48 · 2022: 47 · 2021: 14 · 2020: 1
FWCI
4.32
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
  • RODIN (Universidad de Cádiz) (submittedVersion, cc-by)
  • Repositorio Institucional de la Universidad de Huelva (Universidad de Huelva) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Hispana (submittedVersion, cc-by-nc-nd)
  • Repositorio Institucional de la Universidad de Huelva (Universidad de Huelva) (submittedVersion, cc-by-nc-nd)
  • RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
Funders
  • Instituto de Salud Carlos III (PI18/01316)
  • Biomedical Research and Innovation Institute of Cádiz (INIBiCA) (LII19/16IN-CO24)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
iron metabolism, obesity, metabolic syndrome, childhood obesity, iron homeostasis, iron deficiency, anemia, iron toxicity, Fenton reaction, iron absorption, iron storage, iron transport, iron recycling, non-alcoholic fatty liver disease, type 2 diabetes, dyslipidemia, chronic inflammation
MeSH terms
Cardiovascular Diseases, Child, Diabetes Mellitus, Type 2, Humans, Inflammation, Iron, Obesity, Metabolic Syndrome, Pediatric Obesity, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.